Bevacizumab: a treatment option for recurrent glioblastoma multiforme. - Wikidata - wikimedia - TriplyDB

Bevacizumab: a treatment option for recurrent glioblastoma multiforme.

Bevacizumab: a treatment option for recurrent glioblastoma multiforme.

http://www.wikidata.org/entity/Q33365902

about

Opportunities and challenges for successful use of bevacizumab in pediatrics.Chemotherapy alleviates subacute recurrent glioma-associated refractory cerebral edema by downregulating vascular endothelial growth factor.Advanced imaging techniques in brain tumors.Migration capacity of human umbilical cord mesenchymal stem cells towards glioma in vivo The 9L(LUC)/Wistar rat glioma model is not suitable for immunotherapy.Antitumor activity of dichloroacetate on C6 glioma cell: in vitro and in vivo evaluation.Targeting potassium channels for increasing delivery of imaging agents and therapeutics to brain tumors.Pediatric high-grade gliomas and diffuse intrinsic pontine gliomas.NOS Expression and NO Function in Glioma and Implications for Patient Therapies.Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme.

P2860

Q30454883-1E436D91-834F-4247-B355-C8BA77285DFE Q33415517-7B057C9D-C031-4F66-8E95-E13827CDBD1F Q33517391-1BEF1715-DC89-4F65-8424-3B960AEB430E Q34095283-80C5C8CF-BB55-4F23-B117-20292443889D Q35020839-4FB3FACA-AF0F-4D4D-9C80-DAA787027862 Q36694593-B1B16FBC-C779-4FCB-814E-1BBA0192A2E4 Q36881899-6FFFA859-358D-4CBA-9816-DA1539409D0C Q37564835-60742E56-804F-4382-B3A2-9E00DEF787F5 Q38842322-52A43D21-713D-43F6-8692-46EFE9D6E9C5 Q42060733-84DF88F6-444B-4CBC-93D1-239E9F5B8383

P2860

Bevacizumab: a treatment option for recurrent glioblastoma multiforme.

http://www.wikidata.org/entity/Q33365902

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Bevacizumab: a treatment option for recurrent glioblastoma multiforme.

@ast

Bevacizumab: a treatment option for recurrent glioblastoma multiforme.

@en

type

label

Bevacizumab: a treatment option for recurrent glioblastoma multiforme.

@ast

Bevacizumab: a treatment option for recurrent glioblastoma multiforme.

@en

prefLabel

Bevacizumab: a treatment option for recurrent glioblastoma multiforme.

@ast

Bevacizumab: a treatment option for recurrent glioblastoma multiforme.

@en

P1433

Q33365902-59761150-070C-48DA-AEED-128232E7B991

P1476

Q33365902-D9F72086-972C-4474-8FFA-203BDC5275DE

P2093

Q33365902-46C168F5-661D-4C45-A81C-C7DF0A603ABD

Q33365902-E5D8E5D2-2E63-41D2-B0D7-671A19F47BFD

P2860

Q33365902-13F86217-F9D2-4670-BB61-5E4CB4DABE72

Q33365902-17D9D845-F17D-4726-88ED-5BC675AA5F65

Q33365902-2E6264A1-B593-425E-BB97-0CC3AA2FF216

Q33365902-2FFD5D26-1BF1-4CE1-BC22-79AC4046EF2D

Q33365902-494648D9-4C87-410C-AB13-5F332FAC7BB4

Q33365902-58C5B27C-A1A2-4754-86D9-294D393F5176

Q33365902-6CD286B2-DED3-4620-B05C-05583B032337

Q33365902-87F9CA33-4DFE-4A0D-9B36-580D34C0E2EB

Q33365902-943BD018-9FD5-4D21-8507-70DBAB738594

Q33365902-B00B26E4-E8F2-4D5E-A799-F515E6B6FAB4

P304

Q33365902-BCDDE049-8F39-4FD2-88B6-B1569A23DADE

P31

Q33365902-21bf8583-12ff-4d77-8358-2dc1d743385d

Q33365902-FDF45EC9-5E49-4BBA-B873-F6B7CB57BC66

P356

Q33365902-3F136D8D-DA17-42CB-B4AF-CF9DA1C10C34

P407

Q33365902-FADE191B-EBBC-4EEE-A784-BA91AA2401F2

P433

Q33365902-A4578776-E189-4804-A023-0C745C64830F

P478

Q33365902-625D26AC-0260-4448-8A35-182A412D291F

P577

Q33365902-47CD813D-2FAA-4707-8790-4C0BD15A131E

P698

Q33365902-4499D2F1-04A7-4C71-902C-E235490D0C7F

P921

Q33365902-D2FB55DF-C909-43D9-A0B5-1EF6F43DA14D

P356

P1433

Annals of Pharmacotherapy

P1476

Bevacizumab: a treatment option for recurrent glioblastoma multiforme.

@en

P2093

John Valgus

http://www.w3.org/2001/XMLSchema#string

Larry W Buie

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Diagnosis and treatment of recurrent high-grade astrocytoma.

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.

Clinical impact of adjuvant chemotherapy in glioblastoma multiforme : a meta-analysis.

Genetic pathways to primary and secondary glioblastoma

Recent advances in the treatment of malignant astrocytoma.

'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis.

Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO).

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

Angiogenesis in brain tumours.

P304

1486-1490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1L030

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18765835

http://www.w3.org/2001/XMLSchema#string

P921